Skip to main content

Advertisement

SpringerLink
Log in

Richter’s syndrome in central nervous system with MYD88L265P and CD79b mutation responded well to ibrutinib containing chemotherapy: a case report and review of the literature

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Richter MN (1928) Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 4:285-292.287

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Parikh SA, Rabe KG, Call TG et al (2013) Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients. Br J Haematol 162:774–782

    Article  Google Scholar 

  3. Strati P, Uhm JH, Kaufmann TJ et al (2016) Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia. Haematologica 101:458–465

    Article  CAS  Google Scholar 

  4. Song Y, Zhang W, Zhang L et al (2016) Cerebrospinal fluid IL-10 and IL-10/IL-6 as accurate diagnostic biomarkers for primary central nervous system large B-cell lymphoma. Sci Rep 6:38671

    Article  CAS  Google Scholar 

  5. Elnair R, Ellithi M, Kallam A et al (2021) Outcomes of Richter’s transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database. Ann Hematol 100:2513–2519

    Article  Google Scholar 

  6. Nakanishi T, Ito T, Fujita S et al (2020) Refractory chronic lymphocytic leukemia with central nervous system involvement: a case report with literature review. J Blood Med 11:487–502

    Article  Google Scholar 

  7. Bayliss KM, Kueck BD, Hanson CA et al (1990) Richter’s syndrome presenting as primary central nervous system lymphoma. Transformation of an identical clone. Am J Clin Pathol 93:117–123

    Article  CAS  Google Scholar 

  8. Grommes C, Nayak L, Tun HW et al (2019) Introduction of novel agents in the treatment of primary CNS lymphoma. Neuro Oncol 21:306–313

    Article  Google Scholar 

  9. Parry EM, Guieze R, Leshchiner I et al (2020) Genetic determinants and evolutionary history of Richter’s syndrome. Blood 136:47–48

    Article  Google Scholar 

  10. Tian S, Wang H, Call TG et al (2020) Genomic profiling reveals molecular heterogeneity in patients with Richter’s syndrome (RS) and progressive chronic lymphocytic leukemia (CLL). Blood 136:16–17

    Article  Google Scholar 

  11. Wang H, Tian S, Zhao Q et al (2020) Distinct gene expression signatures in patients with Richter’s syndrome and chronic lymphocytic leukemia with prior exposure to ibrutinib. Blood 136:30–31

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100005, China

    Wei Wang, Yan Zhang, Danqing Zhao, Wei Zhang & Daobin Zhou

Authors
  1. Wei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Danqing Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daobin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

W.W. wrote the first draft of the manuscript, Y.Z. and D.Q.Z provided the data, and W.Z. and D.B. Z. revised the final draft. All authors reviewed and edited the final manuscript before submission.

Corresponding author

Correspondence to Wei Zhang.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

(And/or in case humans were involved)

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, W., Zhang, Y., Zhao, D. et al. Richter’s syndrome in central nervous system with MYD88L265P and CD79b mutation responded well to ibrutinib containing chemotherapy: a case report and review of the literature. Ann Hematol 101, 1869–1872 (2022). https://doi.org/10.1007/s00277-022-04827-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-04827-6

Search

Navigation